Artgen Biotech PJSC (MIC:ABIO) Inventories, Raw Materials & Components : ₽216 Mil (As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC Inventories, Raw Materials & Components?

Artgen Biotech PJSC's inventories, raw materials & components for the quarter that ended in Jun. 2023 was ₽216 Mil.

Artgen Biotech PJSC's quarterly raw materials declined from Jun. 2022 (₽214 Mil) to Dec. 2022 (₽207 Mil) but then increased from Dec. 2022 (₽207 Mil) to Jun. 2023 (₽216 Mil).

Artgen Biotech PJSC's annual raw materials declined from Dec. 2020 (₽217 Mil) to Dec. 2021 (₽206 Mil) but then increased from Dec. 2021 (₽206 Mil) to Dec. 2022 (₽207 Mil).

Artgen Biotech PJSC Inventories, Raw Materials & Components Historical Data

The historical data trend for Artgen Biotech PJSC's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artgen Biotech PJSC Inventories, Raw Materials & Components Chart

Artgen Biotech PJSC Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

133.69

165.60

216.87

206.02

206.68

Artgen Biotech PJSC Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															210.21	206.02	214.06	206.68	215.59

Artgen Biotech PJSC Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Artgen Biotech PJSC (MIC:ABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prospect of the 60th Anniversary, Moscow, RUS, 117036

Website

https://www.hsci.ru

Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.